CS202550B2 - Method of preparing novel derivatives of 1-/benzazolylalkyl/piperidine - Google Patents

Method of preparing novel derivatives of 1-/benzazolylalkyl/piperidine Download PDF

Info

Publication number
CS202550B2
CS202550B2 CS764688A CS468876A CS202550B2 CS 202550 B2 CS202550 B2 CS 202550B2 CS 764688 A CS764688 A CS 764688A CS 468876 A CS468876 A CS 468876A CS 202550 B2 CS202550 B2 CS 202550B2
Authority
CS
Czechoslovakia
Prior art keywords
parts
formula
dihydro
hydrogen
methyl
Prior art date
Application number
CS764688A
Other languages
Czech (cs)
English (en)
Inventor
Jan Vandenberk
Ludo E J Kennis
Der Aa Marcel Van
Heertum Albert Van
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/687,139 external-priority patent/US4066772A/en
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of CS202550B2 publication Critical patent/CS202550B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CS764688A 1975-07-21 1976-07-16 Method of preparing novel derivatives of 1-/benzazolylalkyl/piperidine CS202550B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59779375A 1975-07-21 1975-07-21
US05/687,139 US4066772A (en) 1975-07-21 1976-05-17 1,3-Dihydro-1-[3-(1-piperidinyl)propyl]-2H-benzimidazol-2-ones and related compounds
KR7601697A KR810000334B1 (ko) 1975-07-21 1976-07-12 1-(벤즈 아조릴알킬) 피페리딘 유도체의 제조방법

Publications (1)

Publication Number Publication Date
CS202550B2 true CS202550B2 (en) 1981-01-30

Family

ID=27348142

Family Applications (1)

Application Number Title Priority Date Filing Date
CS764688A CS202550B2 (en) 1975-07-21 1976-07-16 Method of preparing novel derivatives of 1-/benzazolylalkyl/piperidine

Country Status (25)

Country Link
JP (1) JPS5217475A (US08177716-20120515-C00003.png)
AT (1) AT364358B (US08177716-20120515-C00003.png)
AU (1) AU511027B2 (US08177716-20120515-C00003.png)
BG (1) BG26526A3 (US08177716-20120515-C00003.png)
CA (1) CA1085852A (US08177716-20120515-C00003.png)
CH (1) CH623820A5 (US08177716-20120515-C00003.png)
CS (1) CS202550B2 (US08177716-20120515-C00003.png)
DE (1) DE2632870A1 (US08177716-20120515-C00003.png)
DK (1) DK154950C (US08177716-20120515-C00003.png)
ES (3) ES449740A1 (US08177716-20120515-C00003.png)
FI (1) FI62667C (US08177716-20120515-C00003.png)
GB (1) GB1542514A (US08177716-20120515-C00003.png)
HK (1) HK14180A (US08177716-20120515-C00003.png)
IE (1) IE43496B1 (US08177716-20120515-C00003.png)
IT (1) IT1062614B (US08177716-20120515-C00003.png)
KE (1) KE3215A (US08177716-20120515-C00003.png)
LU (1) LU75354A1 (US08177716-20120515-C00003.png)
MY (1) MY8100017A (US08177716-20120515-C00003.png)
NL (1) NL187442C (US08177716-20120515-C00003.png)
NZ (1) NZ181256A (US08177716-20120515-C00003.png)
PH (1) PH13710A (US08177716-20120515-C00003.png)
PT (1) PT65387B (US08177716-20120515-C00003.png)
RO (1) RO70566A (US08177716-20120515-C00003.png)
SE (2) SE426490B (US08177716-20120515-C00003.png)
YU (1) YU39969B (US08177716-20120515-C00003.png)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4501749A (en) * 1983-10-31 1985-02-26 Merck & Co., Inc. Peripherally selective dopamine antagonists in the treatment of ocular hypertension
JPS6248684A (ja) * 1985-08-26 1987-03-03 Sumitomo Chem Co Ltd 新規なヨ−ドブチロフエノン誘導体およびその製造法
JPS62251313A (ja) * 1986-04-25 1987-11-02 信越ポリマー株式会社 結束装置
FR2723091B1 (fr) * 1994-07-29 1996-11-08 Esteve Labor Dr Tetrahydropyridine-(6,4-hydroxypiperidine) alkylazoles
US6355659B1 (en) 1994-07-29 2002-03-12 Laboratorios Del Dr. Esteve, S.A. 4-(4-Chlorophenyl)-1236-tetrahydro-1(1H-124-triazol-1-yl)butty)pyrideine and salts thereof; pharmaceutical compositions and method of treating psychoses utilizing same
JO2785B1 (en) * 2003-05-27 2014-03-15 شركة جانسين فارماسوتيكا ان. في Quinazoline derivatives
JP4936897B2 (ja) 2003-12-18 2012-05-23 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 抗増殖剤としてのピリド−およびピリミドピリミジン誘導体
NI200700147A (es) 2004-12-08 2019-05-10 Janssen Pharmaceutica Nv Derivados de quinazolina inhibidores de cinasas dirigidos a multip
CA2654583C (en) 2006-07-13 2015-11-24 Janssen Pharmaceutica N.V. Mtki quinazoline derivatives
EP1997805A1 (en) * 2007-06-01 2008-12-03 Commissariat à l'Energie Atomique Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
CA2693715C (en) 2007-07-27 2015-10-27 Janssen Pharmaceutica Nv Pyrrolopyrimidines
EP3101018B1 (en) * 2007-08-31 2019-03-06 Purdue Pharma L.P. Substituted-quinoxaline-type-piperidine compounds and the uses thereof
US9090618B2 (en) 2012-12-27 2015-07-28 Purdue Pharma L.P. Substituted benzimidazole-type piperidine compounds and uses thereof
WO2017136617A1 (en) * 2016-02-04 2017-08-10 Cinrx Pharma, Llc Deuterated domperidone compositions and methods for therapy of disorders
KR20240125702A (ko) 2017-06-30 2024-08-19 신돔 파마, 인크. 중수소화 돔페리돈 조성물, 방법, 및 제조

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE633495A (US08177716-20120515-C00003.png) * 1962-06-13
BE633914A (US08177716-20120515-C00003.png) * 1962-06-22
US3629267A (en) * 1968-10-28 1971-12-21 Smith Kline French Lab Benzoheterocyclicalkyl derivatives of 4-(2-keto -1-benzimidazolinyl)-piperidine 4-(2-keto - 1 - benzimidazolinyl) -1 2 3 6 tetrahydropyridine 1 - phenyl - 1 3 8-triazaspiro(4 5)decan - 4 - one and 2 4 9-triazaspiro(5 5)undecan-1 3 5-trione
AU4698672A (en) * 1972-09-22 1972-11-09 Ciba-Geigy Ag Azacycloaliphatic compounds, process for their manufacture and compositions containing them
FR2218100A1 (en) * 1973-02-20 1974-09-13 Janssen Pharmaceutica Nv Neuroleptic tricyclic derivs. - of benzimidazolinones and triazaspiro-4,5-decan-4-ones
US3989707A (en) * 1974-06-21 1976-11-02 Janssen Pharmaceutica N.V. Benzimidazolinone derivatives

Also Published As

Publication number Publication date
FI62667C (fi) 1983-02-10
PT65387B (en) 1978-06-09
SE8008713L (sv) 1980-12-11
DK327576A (da) 1977-01-22
BG26526A3 (bg) 1979-04-12
NL187442B (nl) 1991-05-01
IE43496L (en) 1977-01-21
FI762086A (US08177716-20120515-C00003.png) 1977-01-22
IE43496B1 (en) 1981-03-11
DE2632870A1 (de) 1977-02-10
DK154950C (da) 1989-05-29
SE426490B (sv) 1983-01-24
RO70566A (ro) 1982-10-11
AU1596476A (en) 1978-01-19
SE435621B (sv) 1984-10-08
PT65387A (en) 1976-08-01
NZ181256A (en) 1978-04-28
JPS6131109B2 (US08177716-20120515-C00003.png) 1986-07-17
ES461631A1 (es) 1978-12-01
PH13710A (en) 1980-09-09
ATA534776A (de) 1981-03-15
MY8100017A (en) 1981-12-31
NL7608023A (nl) 1977-01-25
CH623820A5 (en) 1981-06-30
ES461630A1 (es) 1978-06-16
YU179476A (en) 1983-01-21
GB1542514A (en) 1979-03-21
AU511027B2 (en) 1980-07-24
IT1062614B (it) 1984-10-20
AT364358B (de) 1981-10-12
ES449740A1 (es) 1978-02-16
NL187442C (nl) 1991-10-01
YU39969B (en) 1985-06-30
HK14180A (en) 1980-03-28
DK154950B (da) 1989-01-09
DE2632870C2 (US08177716-20120515-C00003.png) 1989-02-16
SE7608265L (sv) 1977-01-22
FI62667B (fi) 1982-10-29
CA1085852A (en) 1980-09-16
JPS5217475A (en) 1977-02-09
LU75354A1 (US08177716-20120515-C00003.png) 1977-02-28
KE3215A (en) 1982-07-09

Similar Documents

Publication Publication Date Title
CS202550B2 (en) Method of preparing novel derivatives of 1-/benzazolylalkyl/piperidine
SU1138032A3 (ru) Способ получени производных бициклического пиримидин-5-она или их солей с фармацевтически приемлемыми кислотами,или их цис- или транс-изомеров
FI71737B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 3-(piperidinylalkyl)-4h-pyrido/1,2-a/ pyrimidin-4-on-derivat
JPS6193183A (ja) 8−(ベンゾアゾリルアルキル)−1,3,8−トリアザスピロ〔4,5〕デカン−4−オン誘導体
AU1345401A (en) 1,4 substituted piperidinyl nmda/nr2b antagonists
HU211524A9 (en) Benzimidazole compounds
HU211490A9 (en) Piperidine derivatives, their preparation and their application in therapeutics
EP0037713B1 (en) Novel 1,3-dihydro-1-((1-piperidinyl)alkyl)-2h-benzimidazol-2-one derivatives
SK279566B6 (sk) Substituované pyroly a ich použitie, spôsob a medz
FI59589C (fi) Analogifoerfarande foer framstaellning av terapeutiskt aktiva bensimidazolinonderivat
PL169740B1 (pl) S p o s ó b w y t w a r z a n i a n o w y c h p o c h o d n y c h 4 H - p i r y d o - [ 1 ,2 - a ] p i r y m i d y n o n u - 4 PL PL
AU2015248936A1 (en) Spiro urea compounds as RSV antiviral compounds
FI63228C (fi) Foerfarande foer framstaellning av 1-bensazolyl-4-substituerade piperidiner anvaendbara saosom neuroleptiska medel
PL113999B1 (en) Process for preparing novel derivatives of 5,11-dihydro-6h-pyrido/2,3-b//1,4/benzodiazepin-6-ones
US5919788A (en) 4-(1H-indol-1-yl)-1-piperidinyl derivatives
US4126687A (en) Antiemetic, 1-(benzimidazolyl-alkyl)-piperidine derivatives
FI83220B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,3-dimetyl-1h-purin-2,6-dionderivat.
US4175129A (en) Antiemetic 1-(benzoxazolylalkyl)-piperidine derivatives
NO148747B (no) Analogifremgangsmaate til fremstilling av n-fenyl-n-(4-piperidinyl)lavere alkyl-tetrazolamider
HU194234B (en) Process for preparing substituted pyrido/1,2-c/imidazo /1,2-a/benzimidazoles and pharmaceuticals comprising the compounds
FI65249C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1-enyl-8-bensimidazol-1-ylpropyl-1,3,8-triazaspiro(4,5)deka n--onderivat
PL118633B1 (en) Method of manufacture of novel derivatives of 1-/benzazolyl-alkyl/-piperidineil/-piperidina
ES2660876T3 (es) Derivados de piridona como inhibidores de la secreción de ácido y proceso para la preparación de los mismos
SI9010198A (sl) Derivati tetrahidrobenzimidazola in postopek za njihovo pripravo
PH26643A (en) Bicyclic heterocyclic containing N-(bicyclic hetero-cyclyl)-4-piperidinamines